Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | CCR5 | P51681 | 9/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | CMA1 | P23946 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9546604 | 0.89 | CCR1 (0.56) | CCR1KMT2ACCR5MEN1CMA1 | |
| SCHEMBL9546589 | 0.89 | CCR1 (0.56) | CCR1KMT2ACCR5MEN1CMA1 | |
| SCHEMBL9546598 | 0.87 | PSEN1 (0.49) | CCR1KMT2ACCR5MAPK1 | |
| SCHEMBL9546605 | 0.87 | PSEN1 (0.49) | CCR1KMT2ACCR5MAPK1 | |
| SCHEMBL9546613 | 0.87 | PSEN1 (0.49) | CCR1KMT2ACCR5MAPK1 | |
| SCHEMBL9546622 | 0.87 | PSEN1 (0.49) | CCR1KMT2ACCR5MAPK1 | |
| SCHEMBL9546474 | 0.84 | CCR1 (0.54) | CCR1KMT2AMEN1CMA1CTSL | |
| SCHEMBL9546845 | 0.83 | KMT2A (0.43) | CCR1KMT2ACCR5MEN1CMA1 | |
| SCHEMBL9546847 | 0.83 | KMT2A (0.43) | CCR1KMT2ACCR5MEN1CMA1 | |
| SCHEMBL9546842 | 0.83 | KMT2A (0.43) | CCR1KMT2ACCR5MEN1CMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993023373-A1 | N-[N'-(5-AMINO-4-HYDROXY-ACYLOYL)-α-AMINOACYLOYL] SUBSTITUTED HETEROCYCLES AND THEIR USE AS ANTIVIRAL AGENTS | PFIZER LIMITED (GB) | 1993-11-25 | — | — | WO | disclosed |